Your browser doesn't support javascript.
loading
Development of a CLDN18.2-targeting immuno-PET probe for non-invasive imaging in gastrointestinal tumors.
Chen, Yan; Hou, Xingguo; Li, Dapeng; Ding, Jin; Liu, Jiayue; Wang, Zilei; Teng, Fei; Li, Hongjun; Zhang, Fan; Gu, Yi; Yu, Steven; Qian, Xueming; Yang, Zhi; Zhu, Hua.
Affiliation
  • Chen Y; Guizhou University Medicine College, Guiyang, 550025, China.
  • Hou X; The Ministry of Education Key Laboratory of Carcinogenesis and Translational Research; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Li D; The Ministry of Education Key Laboratory of Carcinogenesis and Translational Research; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Ding J; Guizhou University Medicine College, Guiyang, 550025, China.
  • Liu J; The Ministry of Education Key Laboratory of Carcinogenesis and Translational Research; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Wang Z; The Ministry of Education Key Laboratory of Carcinogenesis and Translational Research; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Teng F; The Ministry of Education Key Laboratory of Carcinogenesis and Translational Research; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Li H; The Ministry of Education Key Laboratory of Carcinogenesis and Translational Research; NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
  • Zhang F; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan, 646000, China.
  • Gu Y; Suzhou Transcenta Therapeutics Co., Ltd, Suzhou, Jiangsu, 215127, China.
  • Yu S; Suzhou Transcenta Therapeutics Co., Ltd, Suzhou, Jiangsu, 215127, China.
  • Qian X; Suzhou Transcenta Therapeutics Co., Ltd, Suzhou, Jiangsu, 215127, China.
  • Yang Z; Suzhou Transcenta Therapeutics Co., Ltd, Suzhou, Jiangsu, 215127, China.
  • Zhu H; Suzhou Transcenta Therapeutics Co., Ltd, Suzhou, Jiangsu, 215127, China.
J Pharm Anal ; 13(4): 367-375, 2023 Apr.
Article in En | MEDLINE | ID: mdl-37181294
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pharm Anal Year: 2023 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pharm Anal Year: 2023 Document type: Article Affiliation country: China Country of publication: China